SCHEMBL6598566

SCHEMBL6598566

O[CH]c1ccc2ncoc2c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 6/20 0.45
NPC1 O15118 2/20 0.43
RAB9A P51151 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
LMNA P02545 1/20 0.41
MEN1 O00255 1/20 0.40
ALDH1A1 P00352 1/20 0.40
GAA P10253 1/20 0.40
KMT2A Q03164 1/20 0.40
CLK1 P49759 5/20 0.40
CLK4 Q9HAZ1 5/20 0.40
DYRK3 O43781 3/20 0.40
CLK2 P49760 3/20 0.40
CLK3 P49761 3/20 0.40
GSK3B P49841 3/20 0.40
DYRK2 Q92630 3/20 0.40
DYRK4 Q9NR20 3/20 0.40
DYRK1B Q9Y463 3/20 0.40
CDK5 Q00535 2/20 0.40
CDK5R1 Q15078 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3582670 0.81 DYRK1A (0.45) DYRK1ANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL25022821 0.81 DYRK1A (0.45) DYRK1ANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL8058511 0.81 DYRK1A (0.45) DYRK1ANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL13353670 0.78 DYRK1A (0.42) DYRK1ANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL27629454 0.78 LMNA (0.46) DYRK1ANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL926971 0.74 DYRK1A (0.49) DYRK1ANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL24425916 0.73 DYRK1A (0.72) DYRK1ANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL2603491 0.72 EGFR (0.51) NPC1RAB9ASMN1; SMN2LMNAALDH1A1
SCHEMBL116288 0.69 DYRK1A (0.58) DYRK1ANPC1RAB9ASMN1; SMN2LMNA
SCHEMBL1586683 0.69 DYRK1A (0.49) DYRK1ANPC1RAB9ASMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385833-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS Amgen Inc. (US) 2004-02-04 EP disclosed
WO-2002083654-A1 TRIAZINYL AMIDE DERIVATIVES AS ANGIOGENESIS INHIBITORS AMGEN INC. (US) 2002-10-24 WO disclosed